Skip to main content
Premium Trial:

Request an Annual Quote

Pathline Emerge Begins Using GenomOncology Molecular Testing Workflow

NEW YORK (GenomeWeb) – GenomOncology announced today that pathology services company Pathline Emerge has begun using its GO Clinical Workbench for analysis and reporting of next-generation sequencing tests.

Financial terms of the deal were not disclosed.

Pathline partnered with GenomOncology in order to find ways to streamline its workflows and deliver detailed reports to clinicians, the company said in a statement. The GO Clinical Workbench enables labs to configure workflows for molecular tests based on NGS, FISH, karyotyping, RT-PCR, IHC, and others. Specifically, labs can perform quality control analysis, evaluate all variants, and send clinical reports.

"One key area of value creation is being able to provide oncologists with reports that provide decision support over integrated data sets," said GenomOncology President and CEO Manuel Glynias in a statement. "Therapy decisions can change depending on co-occurring genomic aberrations and it's important for the oncologist to understand these potential changes — for example, combining gene fusion data with karyotype results, SNVs, and indels to provide an integrated interpretative report that proposes therapeutic options and suggests appropriate clinical trials."

In November, GenomOncology announced a deal to comarket ArcherDx's next-generation sequencing assays alongside the GO Clinical Workbench, and to support interpretation of several ArcherDx assays, including the ALK, RET, ROS1, Solid Tumor, and Comprehensive Thyroid and Lung panels.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.